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Abstract In this study, the protocol of a single-step L-cys-
teine functionalized silver nanoparticle synthesis was de-
scribed. Particle size distribution was determined. The
crystallinity and chemical properties were investigated
using XRD, HR-TEM, and XPS methods. Acute toxicity
and irritant properties of obtained nanoparticles were stud-
ied using mice and rats as an animal model. The results
showed that thanks to the applied protocol, it was possible
to synthesize silver nanoparticles with narrow particle size
distribution. Moreover, the concentration of final product
was extremely high in comparison to other known
methods. These nanoparticles showed neither irritant prop-
erties nor acute toxicity.
Keywords Silver nanoparticles . Functionalization .
L-cysteine . Toxicity . Drug carrier . Synthesis
Introduction
Throughout the last decades, the nanotechnology has been
considered as a powerful field, which finds out the application
in many areas of science. The progress of nanotechnology is
especially important in clinical medicine, where development
of new drugs, devices, and diagnostic tools improves our life.
In medical application, particular noble metals, such as gold,
platinum, palladium, and silver nanoparticles are considered,
due to their unique chemical and physical properties. These
particles have low toxicity, high compatibility to biological
systems, and can be easily functionalized, which increase the
range of their potential application. For these reasons, gold
nanoparticles are used, e.g., in cancer therapy mainly as drug
carriers (Cobley et al. 2011), delivery vehicles (Galdiero et al.
2011), or markers for imaging (Huang et al. 2006) etc. (Guo
and Sadler 1999) Due to their antibacterial properties, silver
nanoparticles have been used mostly in healthcare industry,
food storage, textile manufacturing, cosmetics (Kokura et al.
2010), and environmental remediation. It is worth noting,
however, that the application of nanoparticles is strictly de-
pendent on their morphology (size, shape, and their size dis-
tribution), which can be easily manipulated by the use of a
suitable manufacturing technique. For example, chemical
methods allow to synthetize nanoparticles of different mor-
phology (Luty-Błocho et al. 2014; Luty-Błocho and
Wojnicki 2015). Among them, only a few synthesis routes
are recommended for medical application as there are prob-
lems with the biocompatibility of reagents, or media, etc.
Thus, in the present study, chemical reduction of metal pre-
cursor with reductant was chosen as a method for the synthesis
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of silver nanoparticles. The main advantages of this technique
are low cost, simplicity, and the opportunity to synthetize the
nanoparticles which size around 9 nm. Dimethylamine borane
was used as an effective reducing agent of silver ions
(Wojnicki et al. 2015). In order to exclude a negative effect
coming from products of nanoparticle synthesis, the solution
after redox reaction was dialyzed (see the BSilver nanoparticle
synthesis and characterization^ section for more details). This
method allows to remove all dangerous agents. In this paper,
the special attention was focused on the functionalization of
silver nanoparticles for cosmetic application.
Materials and methods
Silver nanoparticle synthesis and characterization
Silver nanoparticle synthesis was performed using silver(I)
nitrate(V) (AgNO3, Avantor Materials) as precursor. Borane
dimethylamine complex of 97% (DMAB, Fluka) was used as
the reducing agent. L-cysteine was used as stabilizer as well as
functionalizing compound. AgNPs were synthesized as fol-
lows: 0.2 M aqueous solution of AgNO3 was mixed in a 1:1
ratio with the aqueous solution containing 0.4 M of L-cysteine
and 1 M of sodium hydroxide (Avantor Materials). Such a
solution has lightly yellow color due to the formation of L-
cysteine-Ag+ complex. Then, freshly prepared aqueous solu-
tion containing 0.3 M DMAB in 0.1 M NaOH was mixed in a
1:1 volumetric ratio with L-cysteine-Ag+ containing solution.
After mixing, the color of the solution was gradually changing
from light yellow by red to dark brown.
It is worth to mention here that increase of DMAB initial
concentration affects the decrease of particle size. However,
there is no linear correlation between reductant concentration
and particle size.
The dialysis method was applied to remove the residues
after redox reaction. For this purpose, the Medical
International Size 9 Int. Dia. 36/32″ dialysis tubing was ap-
plied. The dialysis was performed for ca. 5 days. The contin-
uous water exchange was set at 20mL/min. Thanks to that, the
pH level decreased to ca. 7. Also, the specific odor of
dimethylamine was removed. Then, the solution was filtered
using a Whatman PC MB membrane of 47 mm in diameter
and the pore size of 50 nm. This solution was used for further
analysis and experiments.
Zeta potential as well as particle size distribution of the
obtained composite material was determined using a
Zetasizer Nano ZS (Malvern). A standard clear polycarbonate
cell with gold electrodes was applied.
UV-Vis spectra were registered using a Shimadzu model
U-2501 PC and quartz cuvette of 10 mm path length.
Fluorescence spectra were measured using a PerkinElmer
LS55 spectrofluorometer in a 1 cm quartz cuvette.
HR-TEM analysis was performed using HR-TEM—FEI
TECNAI TF 20 X-TWIN. One drop of freshly prepared col-
loidal suspension was placed on a copper grid covered with a
20–30-nm amorphous carbon film. Then, the sample was left
to dry at room temperature (ca. 21 °C).
Particle size and size distribution were determined after
analyzing of HR-TEM images using ImageJ application
(ver. 1.48b).
X-ray photoelectron spectroscopy measurements were per-
formed using a PHI 5000 Versa Probe II (ULVAC-PHI,
Chigasaki, Japan) system using a microfocused (100 μm,
25 W) Al Kα X-ray beam with a photoelectron take-off angle
of 45°. To compensate the charging effect, a dual-beam charge
neutralizer was used. The operating pressure in the analytical
chamber was less than 5 × 10−7 Pa. High-resolution spectra
were collected with analyzer pass energy of 23.50 eV. XPS
spectra were acquired from 400 × 300 μm (Galdiero et al.
2011) areas. All XPS peaks were referenced to the neutral
(C-C) carbon C 1s peak at 284.8 eV. Spectrum background
was subtracted using the Shirley method. Data analysis soft-
ware from PHIMultiPak was used to calculate elemental com-
positions from the peak areas.
Animal studies
Adult female Albino Swiss mice weighing 28–33 g were used
in the study. They were kept in environmentally controlled
rooms, in standard cages lit by an artificial light for 12 h.
Animals had free access to food and water. The randomly
established experimental groups consisted of six mice.
Male Wistar rats of initial body weight from 200 to 230 g
were also used. The animals were housed in plastic cages in
constant temperature facilities exposed to 12–12 light-dark
cycle. Water and food were available ad libitum. The solution
of nanoparticles was administered on the shaved skin of the
abdomen.
The solution of nanoparticles was administered intraperito-
neally (i.p.)—group no. 1 or intragastrically by means of an
oral gavage (p.o.)—group no. 2. The volume of the test solu-
tion was 10 mL/kg. Nothing was given to the control group—
group no. 3.
All animal care and experimental procedures were carried
out in accordance with European Union and Polish legislation
acts concerning animal experimentation and approved by the
Local Ethics Committee at the Jagiellonian University in
Krakow.
Acute toxicity, plasma, and tissue collection
After administration of tested solution, mice were placed into
the home cages and observed. The percent of death and body
weight changes were determined during 24 h. Subsequently,
heparin (500 j/mice) and thiopental (70 mg/kg i.p.) for each
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animal was administrated. After 20 min, blood was collected
from left common carotid artery. The animal spinal cord was
interrupted, cut, and organs, namely the liver, kidneys, heart,
brain, and lungs were weighted to determine the amount of
nanosilver.
Topical toxicity and skin collection
Thiopental (70 mg/kg i.p.) was administrated to each animal.
After 20min, the abdominal skin was smeared with depilatory
cream (Joanna Sensitive, Poland), and 10 min later, the skin
was wiped using a cotton swab moistened with 0.9% saline.
The solution of nanoparticles (0.3 ml/animals) was adminis-
tered on the skin. The percent of death and body weight
changes were determined during 24 h. Subsequently,
thiopental (70 mg/kg i.p.) was administrated to each animal.
After 20 min, the skin was collected.
Statistical analysis
The results obtained were analyzed using a two-way analysis
of variance (ANOVA), followed by a Bonferroni post-hoc test
with the significance level set at 0.05 (body weight changes).
The outcomes were expressed as the means ± standard error of
the mean (SEM). GraphPad Prism 6.0 was used for data
analysis.
Metal concentration determination
The biodistribution of AgNPs was investigated in selected
organs. For this purpose, after 24 h, the liver, kidneys, heart,
Fig. 1 Survey scan performed with X-ray photoelectron spectroscopy of AgNPs (a). XPS spectra with fitted lines C 1s (b), Ag 3d (c), and S 2p (d)
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brain, and lungs were collected to determine the amount of
nanosilver. Then, these organs were weighted and mineralized
to extract silver. The extraction was performed according to
protocol described in our previous papers (Wojnicki et al.
2013; Bednarski et al. 2015). The metal concentration was
performed using spectrometer a 4200MP-AES Agilent.
Results
AgNP characterization
X-ray photoelectron spectroscopy (XPS) of AgNPs confirmed
the presence of silver nanoparticles with cysteine conjugated
to the surfaces of the nanoparticles. The survey scan also
indicated the presence of Ag, O, C, S, N, and Na elements in
the sample (Fig. 1a). The atomic concentrations of each element
were determined to be as the following: C 1s—54.56%; N 1s—
6.05%; O 1s—21.29%; S 2p—5.24%; Ag 3d—10.71%; and
Na 1s—2.15%. Detailed analysis of selected elements and
bound type in AgNPs is shown in Fig. 1b–d. Figure 1b shows
spectrum of C 1s with fitted peaks that come from cysteine
bounded to nanoparticle surfaces: peak at 286.0 eV corresponds
to C-N and C-S bonds while at 287.8 eV comes from O-C=O
group in cysteine structure (Cavalleri et al. 2001). Ag 3d spec-
trum (Fig. 1c) can be fitted by two doublets with binding ener-
gies of the Ag 3d5/2 component at 368.2 and 368.7 eV (DS =
6.0 eV), respectively. First peak is attributed to metallic Ag,
while the second is attributed to Ag-S from nanoparticle-
cysteine bonds (Tong et al. 2015; Ferraria et al. 2012). These
Fig. 3 Particle size distribution determined using a DLS method and b HR-TEM image analysis method
Fig. 2 a UV-Vis spectrum of obtained AgNPs. b Determination of absorption coefficient
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results confirmed that cysteine was chemically bonded to
AgNP surfaces. Figure 1d shows S 2p spectrum. Peak
deconvolution revealed presence of two chemical states of sul-
fur at 161.4 and 162.6 eV for S 2p3/2. The first corresponds to
Na-S bond formed by cysteine in alkaline solution. This sug-
gests that cysteine could be also physically adsorbed on the
particle surfaces. The second peak comes from Ag-S bonds
between particle and cysteine (Battocchio et al. 2014).
It is well known that the silver sulfide is a semiconductor,
and its presence in the system should be observable in the UV-
Vis spectra. In the case of AgNPs, their presence can also be
confirmed thanks to plasmon resonance peak. Therefore, UV-
Vis analyses were performed, and results obtained are shown
in Fig. 2a.
In Fig. 2a, UV-Vis spectra of the solutions are shown. It has
to be underlined that these spectra were recorded for diluted
samples. The samples were diluted from 50 to 300 times,
respectively. As it can be seen, one asymmetrical peak at the
wavelength of 482 nm can be observed. This peak can be
attributed to surface plasmon resonance (Darroudi et al.
2010). The red shift of plasmon resonance might be related
to L-cysteine molecule on the surface of AgNPs (Knauer et al.
2013). It should be noted that UV-Vis analysis did not confirm
the presence of Ag2S.
The absorption coefficient of synthetized colloid can be
calculated taking into account the assumption that the absor-
bance is a linear function of the colloid concentration, accord-
ing to Lambert-Beer’s law. From the slope of colloid concen-
tration vs. absorbance, the absorption coefficient can be deter-
mined (see Fig. 2b). The slope is equal to 7.49 ± 0.48 Lgcm,
and the intercept is 0.13 ± 0.06.
Particle size and size distribution as well as zeta potential
were determined using a Malvern instrument. The zeta
potential determined using this equipment is equal to − 50.6
± 4.47 mV. Strong negative zeta potential is probably related
to the zwitterionic properties of L-Cysteine (Quesada-Moreno
et al. 2014). Deprotonation of L-cysteine depends on pH. Two
forms are present in the system at a pH of 7. The first one is the
zwitterion and anionic form. Moreover, using DLS method,
particle size and size distribution were determined. The results
are shown in Fig. 3a. To make it clear, in Fig. 3b, particle size
distribution determined using HR-TEM images is also shown.
As it can be seen, the main fraction is of about 8 nm in
diameter using DLS as well as HR-TEM image analysis meth-
od. It should also be noted that the distribution of the particle
size is symmetrical, whereas typical methods of nanoparticle
synthesis result in log-normal particle size distribution. In case
of HR-TEM image analysis method, particle size distribution
seems to be wider and is equal to ca. 3.2 nm. During HR-TEM
image analysis, 53 particles were analyzed (n = 53).
Fig. 4 HR-TEM analysis (a) and
selection of polycrystal structure
(b) FFT analysis of single crystal
(c)
Fig. 5 XRD pattern of obtained AgNPs
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The HR-TEM analysis was performed (Fig. 4a); the parti-
cle size was comparable to that determined using DLS
method.
Moreover, FFT analysis of a selected picture (red square in
Fig. 4a) was performed to obtain the information about crys-
tallography of synthetized material (Fig. 4c). Selected crystal
plane are marked on the diffractogram. The angle between
planes (111) and (002) is equal to 54°, which is in agreement
to the literature. However, it should be underlined that obtain-
ed nanoparticles have polycrystalline structure.
The results of further analyses of AgNPs carried out using
XRD are shown in Fig. 5.
There is only one sharp peak. Low intensity of this peak is
related to the particle size. As it was shown in Fig. 4a, obtain-
ed nanoparticles have polycrystal structure, where single grain
size is significantly lower than 3 nm. Therefore, the peak
broadening is observed which is also related to the
Scherrer’s equation. Unfortunately, neither HR-TEM analysis
nor XRD analysis confirmed the presence of Ag2S in the
synthetized material. This might be related to the thickness
of Ag2S layer. In the presence of silver sulfide on the surface
of AgNPs, an additional optical effect should be observed,
related directly to the semiconducting properties of Ag2S.
That was the reasonwhy the samples were also analyzed using
fluorescence method. It is well known that silver sulfide ex-
hibits quantum dots properties. Xiulan Wu et.al (2015) have
shown that for spherical Ag2S nanoparticles of 5 nm in diam-
eter, the maximum emission peak appears at the wavelength of
ca. 750 nm, after excitation at 520 nm. It should also be
underlined that Ag2S nanoparticles obtained by Xiulan Wu
et al. were also functionalized using L-cysteine (Fig. 6).
As it can be seen from Fig. 6, the fluorescence of the sam-
ple is related to L-cysteine present on the surface of AgNPs.
Insignificant changes in the left shoulder of the fluorescence
curve of AgNPs are related to the absorption bend of metallic
silver, as it is shown in Fig. 2a. There is no fluorescence above
600 nm. However, a small peak at 525 nm appears. This
suggests that Ag-S bonding visible in XPS (see Fig. 1c) is
related to the chemisorption of L-cysteine on the surface of
AgNPs.
Body weight changes in experimental animals
There were no significant changes in body weight of mice
24 h after intraperitoneal (i.p.) administration of the test solu-
tion in comparison to changes of bodyweight inmice from the
control group (p = 0.0621). After intragastric (p.o.) adminis-
tration, the changes of the body weight of tested mice were
significantly lower in comparison to the body weight changes
stated in mice (p = 0.0398). These results are shown in Fig. 7.
Fig. 7 Bodyweight changes. aComparison of control group to tested group after intraperitoneal administration. bComparison of control group to tested
group after intragastric administration. Mean ± SEM, n = 6. Statistical significance: *p < 0.05 (two-way ANOVA)
Fig. 6 Fluorescence of AgNPs functionalized with L-cysteine
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AgNP acute toxicity and biodistribution
Acute toxicity is extremely important parameter for new drug
safety. Thus, two ways of AgNP administration were chosen.
The first one was intraperitoneal, and the second one was
intragastric. During these trials, sedation of animals was not-
ed. However, there was no death during the first 24 h. It can be
concluded that synthesized AgNPs do not exhibit acute toxic-
ity after intragastric and intraperitoneal administration.
Then, the mice were sacrificed and selected organs were
removed for further analyses. The results of silver nanoparti-
cles biodistributions are gathered and shown in Table 1.
The amount of AgNPs determined in selected organs is
low. Only in the case of intraperitoneal administration, a sig-
nificant accumulation in the liver was stated. The absorption
from the digestive tract is very low. These results are compa-
rable to our previous report (Bednarski et al. 2015). However,
it should be stressed that the amount of AgNPs absorbed from
the digestive tract is about two times higher in comparison to
gold nanoparticles (Bednarski et al. 2015) .
Irritating test
Additionally, an irritating test on the rate skin was performed.
About 300 μL of AgNPs suspension was rubbed into the skin
of rats (n = 3). After 24 h, no irritating effect was observed.
Moreover, the presence of the silver in the blood was not
detected. This in turn suggests that dermal absorption also
does not occur, which indicates that AgNPs can be safely used
in cosmetics.
Conclusions
The antibacterial properties of silver nanoparticles are well
known. In this paper, a simple and effective method for silver
nanoparticle synthesis was described. These nanoparticles
showed excellent biocompatibility. Thanks to the application
of L-cysteine silver complex, it was possible to obtain the
concentration of colloid equal to up to 10.7 g/L. Such a high
concentration of colloid is extremely difficult to synthesize in
one step. The only requirement for the developed method is
the purification process, in order to remove leftover of reduc-
tant and L-cysteine.
Moreover, narrow particle size distribution of the colloid
makes its behavior in living organism easy to investigate.
Since the properties of nanoparticles depend on their size, in
the case of polydisperse samples, the assessment of the bio-
logical effect can be fuzzy as different fractions can give dif-
ferent responses. Finally, it is worth mentioning that L-cyste-
ine was applied as a stabilizing agent. This simple amino acid
can be easily used to link an antibody or any other compound
to the surface of nanoparticles.
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Table 1 AgNP biodistribution in selected organs in percentage of given dose
Brain Kidneys Liver Blood
After P.O administration
1.82 × 10−2 ± 5.79 × 10−3 1.55 × 10−2 ± 2.21 × 10−3 6.53 × 10−2 ± 2.87 × 10−2 4.16 × 10−2 ± 1.51 × 10−2
After I.P administration
3.59 × 10−2 ± 1.52 × 10−3 2.98 × 10−1 ± 6.24 × 10−2 2.93 ± 4.31 × 10−1 9.45 × 10−2 ± 5.46 × 10−2
Naunyn-Schmiedeberg's Arch Pharmacol (2018) 391:123–130 129
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Battocchio C, Fratoddi I, Fontana L, Bodo E, Porcaro F,Meneghini C, Pis
I, Nappini S, Mobilio S, Russo MV, Polzonetti G (2014) Silver
nanoparticles linked by a Pt-containing organometallic dithiol
bridge: study of local structure and interface by XAFS and SR-
XPS. Phys Chem Chem Phys 16(23):11719–11728. https://doi.
org/10.1039/C4CP01264J
Bednarski M, Dudek M, Knutelska J, Nowiński L, Sapa J, Zygmunt M,
Nowak G, Luty-Błocho M, Wojnicki M, Fitzner K, Tęsiorowski M
(2015) The influence of the route of administration of gold nanopar-
ticles on their tissue distribution and basic biochemical parameters:
in vivo studies. Pharmacol Rep 67(3):405–409. https://doi.org/10.
1016/j.pharep.2014.10.019
Cavalleri O, Oliveri L, Daccà A, Parodi R, Rolandi R (2001) XPS mea-
surements on l-cysteine and 1-octadecanethiol self-assembled films:
a comparative study. Appl Surf Sci 175–176:357–362
Cobley CM, Chen J, Cho EC, Wang LV, Xia Y (2011) Gold nanostruc-
tures: a class of multifunctional materials for biomedical
applications. Chem Soc Rev 40(1):44–56. https://doi.org/10.1039/
B821763G
Darroudi M, Ahmad MB, Abdullah AH, Ibrahim NA, Shameli K (2010)
Effect of accelerator in green synthesis of silver nanoparticles. Int J
Mol Sci 11(10):3898–3905. https://doi.org/10.3390/ijms11103898
Ferraria AM, Carapeto AP, Botelho do Rego AM (2012) X-ray photo-
electron spectroscopy: silver salts revisited. Vacuum 86(12):1988–
1991. https://doi.org/10.1016/j.vacuum.2012.05.031
Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M
(2011) Silver nanoparticles as potential antiviral agents. Molecules
16(10):8894–8918. https://doi.org/10.3390/molecules16108894
Guo Z, Sadler PJ (1999)Metals in medicine. AngewChem Int Ed 38(11):
1512–1531. https://doi.org/10.1002/(SICI)1521-3773(19990601)
38:11<1512::AID-ANIE1512>3.0.CO;2-Y
Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imag-
ing and photothermal therapy in the near-infrared region by using
gold nanorods. J Am Chem Soc 128(6):2115–2120. https://doi.org/
10.1021/ja057254a
Knauer A, Schneider S, Möller F, Csáki A, Fritzsche W, Köhler JM
(2013) Screening of plasmonic properties of composed metal nano-
particles by combinatorial synthesis in micro-fluid segment se-
quences. Chem Eng J 227(0):80–89. https://doi.org/10.1016/j.cej.
2012.10.008
Kokura S, Handa O, Takagi T, Ishikawa T, Naito Y, Yoshikawa T (2010)
Silver nanoparticles as a safe preservative for use in cosmetics.
Nanomed Nanotechnol Biol Med 6:570–574
Luty-Błocho M, Wojnicki M (2015) Single-step synthesis of onion-like
Au–Pd–PtNPs nanoparticles using microflow system. J Flow Chem
5(4):197–200. https://doi.org/10.1556/1846.2015.00026
Luty-Błocho M, Wojnicki M, Grzonka J, Kurzydłowski KJ (2014) The
synthesis of stable platinum nanoparticles in the microreactor. Arch
Metall Mater 59(2):509–512
Quesada-Moreno MM, Avilés-Moreno JR, Márquez-García AA, López-
González JJ (2014) Deducing the molecular properties of zwitter-
ionic, protonated, deprotonated, and double-deprotonated forms of
L-cysteine from vibrational spectroscopy (IR, Raman, VCD) and
quantum chemical calculations. J Mol Model 20(6):1–15
Tong J, Wang YJ, Wang Z, Sun JZ, Tang BZ (2015) Crystallization-
induced emission enhancement of a simple tolane-based mesogenic
luminogen. J Phys Chem C 119(38):21875–21881. https://doi.org/
10.1021/acs.jpcc.5b06088
Wojnicki M, Luty-BlochoM, Bednarski M, Dudek M, Knutelska J, Sapa
J, Zygmunt M, Nowak G, Fitzner K (2013) Tissue distribution of
gold nanoparticles after single intravenous administration in mice.
Pharmacol Rep 65(4):1033–1038. https://doi.org/10.1016/S1734-
1140(13)71086-7
Wojnicki M, Zabieglińska K, Luty-Błocho M (2015) Influence of exper-
imental condition on silver nanoparticle synthesis process in aque-
ous solutions. Ores Non-Ferrous Metals 60(3):103–109
Wu X, Liao L, Du W, Qin A (2015) Near infrared emission of Ag2S
quantum dots and their fluorescence quenched by gold nanoparti-
cles. Proc Eng 102:273–277. https://doi.org/10.1016/j.proeng.2015.
01.143
130 Naunyn-Schmiedeberg's Arch Pharmacol (2018) 391:123–130
